RheumNow Week in Review – 16 September 2016 Save
Dr. Jack Cush reviews highlights in the news and journals from this past week at RheumNow.
- 40 die daily in US from narcotics. Rx opioid overdose & abuse has an estimated economic burden 78.5 billion in USA https://t.co/XW78zdYthn
- The new rituximab biosimilar CT-P10 shows comparable results to original rituximab (efficacy, pharmacodynamics, and immunogenicity/safety) https://t.co/hNjcxbF9Mu
- TNFi induced Psoriasis can be treated w/ TNFi D/C, another TNFi (48-85% recurrence) or Stelara. Good short review https://t.co/PAtJOOfFIV
- It's the engine that kills ya’, not the caboose. Dr Cush focuses on the toxic potential of disease activity https://t.co/tCcbiy3anV
- EMA/FDA grants orphan status to Nintedanib (a kinase inhib) for Scleroderma, largely based on it’s approval for ILD. The PSS trial is in progress https://t.co/cdo0kZ5ETx
- Mayo Scleroderma study -severe dysmotility is more in diffuse > limited dz; but Scleroderma esophagus in 1/3 of both https://t.co/WqqFLmTieq
- 180 pts with head & neck cancer treated w/ TNFi or DMARD- TNFi did not increase risk of cancer recurrence (HR 0.75) https://t.co/7tbhO4V0To
- CDC Flu vaccine rules 2016-17 - NO flumyst use, give injx flu vaccine before end October, Egg allergy observe 15 min https://t.co/yNLuFhL9UQ
- CDC Reports 31 Million Older Americans Don't Get Adequate Exercise
- New Shingles Vaccine (Shingrix) Effective for up to Four Years.
- CPAP Use Fails to Prevent CV Events in Sleep Apnea Patients
ADD THE FIRST COMMENT
Disclosures
The author has no conflicts of interest to disclose related to this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.